Banoxantrone
Based on 11 publication(s) in Google Scholar
Banoxantrone (AQ4N), as a prototype hypoxia selective cytotoxin, can be reduced to AQ4, a potent topoisomerase II inhibitor. Banoxantrone selectively kills hypoxic cells via an iNOS-dependent mechanism. Banoxantrone shows a potent cytotoxicity and hypoxia-selective effect enhanced by radiation.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 136470-65-0
- Formule: C22H28N4O6
- Masse moléculaire:444.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Banoxantrone
More- ACS Nano. 2024 Jul 16;18(28):18412-18424. [Abstract]
- J Nanobiotechnology. 2026 Feb 1;24(1):200. [Abstract]
- Adv Sci (Weinh). 2026 Jan 18:e21886. [Abstract]
- Chem Eng J. 2025 Feb 1.
- J Control Release. 2025 Jul 10:383:113789. [Abstract]
- Mater Today Bio. 2026 May 17:38:103244. [Abstract]
- Mater Today Bio. 2025 Dec 15:36:102695. [Abstract]
- Acta Biomater. 2022 Sep 15:150:337-352. [Abstract]
- J Colloid Interface Sci. 2026 Apr 15:708:139847. [Abstract]
- Int J Nanomedicine. 2024 Apr 8:19:3367-3386. [Abstract]
- J Mol Med (Berl). 2019 Aug;97(8):1183-1193. [Abstract]
Activité biologique
Description
IC50 & Target
[1]|
iNOS |
In Vitro
Banoxantrone (20 μM; 90 min) selectively induces cells damage in hypoxia T50/80 tumour cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 136470-65-0
-
Masse moléculaire 444.48
-
Formule C22H28N4O6
-
SMILES
O=C1C2=C(C(O)=CC=C2O)C(C3=C(NCC[N+](C)(C)[O-])C=CC(NCC[N+](C)(C)[O-])=C13)=O
-
Synonyms
AQ4N
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (11)
-
Journal Impact Factor
-
Most Recent
-
ACS Nano
Hypoxia-Specific Metal-Organic Frameworks Augment Cancer Immunotherapy of High-Intensity Focused Ultrasound. [Abstract]2024 Jul 16;18(28):18412-18424. PMID: 38949962 -
J Nanobiotechnology
HIFU postoperative hypoxia-activated metal-organic frameworks modulate the tumor microenvironment to augment immunotherapy. [Abstract]2026 Feb 1;24(1):200. PMID: 41622222 -
Adv Sci (Weinh)
Fluorinated Hypoxia-Responsive Aza-BODIPY for NIR-II FL/19F MR/PA Imaging and Phototherapy of Lung Cancer. [Abstract]2026 Jan 18:e21886. PMID: 41549220 -
-
J Control Release
Hypoxia-responsive albumin nanoparticles co-delivering banoxantrone and STING agonist enhance immunotherapy of high-intensity focused ultrasound. [Abstract]2025 Jul 10:383:113789. PMID: 40318808 -
Mater Today Bio
2026 May 17:38:103244. PMID: 42211060 -
Mater Today Bio
Hypoxia-specific metal-organic frameworks combined with lactate immunometabolism regulation augment anti-tumor immunity of HIFU. [Abstract]2025 Dec 15:36:102695. PMID: 41509979 -
Acta Biomater
Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy. [Abstract]2022 Sep 15:150:337-352. PMID: 35931281 -
J Colloid Interface Sci
Manganese-based metal-organic frameworks augment postoperative immunotherapy of high-intensity focused ultrasound. [Abstract]2026 Apr 15:708:139847. PMID: 41518922 -
Int J Nanomedicine
Folic Acid Functionalized AQ4N/Gd@PDA Nanoplatform with Real-Time Monitoring of Hypoxia Relief and Enhanced Synergistic Chemo/Photothermal Therapy in Glioma. [Abstract]2024 Apr 8:19:3367-3386. PMID: 38617794 -
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
[1]. Hejmadi MV, et al. DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells. Br J Cancer. 1996 Feb;73(4):499-505. [Content Brief]
[2]. Mehibel M, et al. Radiation enhances the therapeutic effect of Banoxantrone in hypoxic tumour cells with elevated levels of nitric oxide synthase. Oncol Rep. 2016 Apr;35(4):1925-32. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)